Best Practices for Monitoring Surfaces for Hazardous Drug Contamination: Consensus Conference Recommendations and Next Steps

A Virtual Midday Symposium conducted at the 2020 ASHP Midyear Clinical Meeting and Exhibition
(Midyear registration not required)

Thursday, December 10, 2020
1:00 – 2:30 p.m. ET


Available at least 24 hours before webinar.

Surface contamination with hazardous drugs (HDs) is an ongoing concern that has been addressed in published standards and best practice guidelines by many organizations, including ASHP, National Institute for Occupational Safety and Health, American Society of Clinical Oncology, Oncology Nursing Society, and Hematology/Oncology Pharmacy Association. However, even with knowledge that HDs pose a threat to healthcare workers and patients, environmental wipe sampling is underused in health systems. In this activity, the faculty review recommendations from the safetotouch National Consensus Conference on Hazardous Drug Surface Contamination held in September 2020 and share approaches for improving awareness of best practices in monitoring surfaces for contamination with hazardous drugs within health systems, including patient care areas. Strategies for implementing procedures for HD surface contamination monitoring are also discussed.

Target Audience

This activity was planned to meet the educational needs of pharmacists, pharmacy technicians, and nurses involved with handling hazardous drugs in hospitals and health systems.


This activity features slide presentations, active learning, and questions/discussion with faculty. 


Learning Objectives

  • List high-priority recommendations from the recent national consensus conference on hazardous drug surface contamination.
  • Describe the importance of healthcare personnel awareness of surface monitoring to detect hazardous drug (HD) contamination.
  • Develop a plan for adopting best practices in HD surface contamination monitoring in the health system.

1:00 p.m.
Review of the safetotouch National Consensus Conference on Hazardous Drug Surface Contamination
Michael Ganio, Pharm.D., M.S., BCPS, FASHP

1:20 p.m.
Monitoring Surfaces in Patient Care Areas for Hazardous Drug Contamination
Martha Polovich, Ph.D., RN, AOCN-Emeritus

1:40 p.m.
Practical Approaches for Adopting Best Practices for Monitoring Hazardous Drug Surface Contamination
Patricia C. Kienle, M.P.A., BCSCP, FASHP

2:00 p.m.
Faculty Discussion and Q&A: Breaking Down Barriers to Put Recommendations into Practice
All Faculty



Michael Ganio, Pharm.D., M.S., BCPS, FASHP, Activity Chair
Senior Director, Pharmacy Practice and Quality
Bethesda, Maryland

Patricia C. Kienle, M.P.A., BCSCP, FASHP
Director, Accreditation and Medication Safety
Cardinal Health Innovative Delivery Solutions
Wilkes-Barre, Pennsylvania

Martha Polovich, Ph.D., RN, AOCN-Emeritus
Adjunct Assistant Professor
Georgia State University
Atlanta, Georgia

CPE Information

ACPE #: 0204-0000-20-439-L07-P & T
Activity Type: Application-based
CE Credits: 1.5 hours
Activity Fee: Free of charge

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


Nurse CE Information

This activity has been submitted to The Maryland Nurses Association for approval to award contact hours. The Maryland Nurses Association is accredited as an approver of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Claim CE by February 1, 2021

Claim CE (enter the CE code announced during activity and complete the evaluation).

Verify credit has posted to your ​NABP eProfile account before the 60-day deadline.

After ACPE's 60-day deadline, ASHP will no longer be able to report credits.

Join the Live Broadcast

Join the live interactive webinar using your computer or smart device. 

Watch for a confirmation email with additional instructions. 

Get the app and view system requirements